Explorer
Will we get nod for vaccine's emergency use? DCGI press conference at 11 am
The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
India
BREAKING: Rahul Gandhi's Police Station Protest Intensifies as Congress Demands FIR in Pellet Gun Case
BREAKING: Rahul Gandhi Stages Sit-In Outside Delhi Police Station, Demands FIR Over Pellet Gun Case
Breaking News: Rahul Gandhi Seeks FIR Over Alleged Pellet Gun Use Against Students in Delhi
Breaking: Rahul Gandhi Demands FIR Over Alleged Pellet-Gun Use on Students, Stays at Delhi Police Station
Breaking: Rahul Gandhi at Delhi Police HQ: Possible Jantar Mantar Pellet-Gun Complaint Under Review
View More
Top Headlines
World
Ceuta Dream: Why Young Moroccans Still Risk Everything To Cross Into Spain
India
‘Why So Scared Of Justice?’ Rahul Gandhi Targets Amit Shah Amid Row Over Pellet Injury Victim’s FIR
Science
China’s Chang’e-7 Mission To Hunt For Lunar Ice In One Of The Solar System’s Coldest Places
India
Rahul Gandhi Sits On Dharna Outside DCP Office Over Pellet Gun Victim’s FIR
Trending News
